nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—SCNN1D—nose—bone cancer	0.357	0.562	CbGeAlD
Triamterene—SCNN1A—nose—bone cancer	0.279	0.438	CbGeAlD
Triamterene—Irreversible renal failure—Cisplatin—bone cancer	0.113	0.311	CcSEcCtD
Triamterene—Renal failure chronic—Cisplatin—bone cancer	0.0397	0.109	CcSEcCtD
Triamterene—Anaemia megaloblastic—Methotrexate—bone cancer	0.0249	0.0683	CcSEcCtD
Triamterene—Azotaemia—Methotrexate—bone cancer	0.011	0.0302	CcSEcCtD
Triamterene—Hyperkalaemia—Cisplatin—bone cancer	0.0105	0.0288	CcSEcCtD
Triamterene—Renal failure acute—Cisplatin—bone cancer	0.0084	0.0231	CcSEcCtD
Triamterene—Hypokalaemia—Cisplatin—bone cancer	0.00706	0.0194	CcSEcCtD
Triamterene—Hyperkalaemia—Epirubicin—bone cancer	0.00539	0.0148	CcSEcCtD
Triamterene—Blood urea increased—Epirubicin—bone cancer	0.00518	0.0142	CcSEcCtD
Triamterene—Hyperkalaemia—Doxorubicin—bone cancer	0.00499	0.0137	CcSEcCtD
Triamterene—Photosensitivity—Methotrexate—bone cancer	0.00485	0.0133	CcSEcCtD
Triamterene—Blood urea increased—Doxorubicin—bone cancer	0.00479	0.0132	CcSEcCtD
Triamterene—Renal failure acute—Methotrexate—bone cancer	0.00461	0.0127	CcSEcCtD
Triamterene—Photosensitivity—Epirubicin—bone cancer	0.00454	0.0125	CcSEcCtD
Triamterene—Renal failure acute—Epirubicin—bone cancer	0.00431	0.0118	CcSEcCtD
Triamterene—Photosensitivity—Doxorubicin—bone cancer	0.0042	0.0115	CcSEcCtD
Triamterene—Renal failure acute—Doxorubicin—bone cancer	0.00399	0.011	CcSEcCtD
Triamterene—Anaphylactic shock—Cisplatin—bone cancer	0.00381	0.0105	CcSEcCtD
Triamterene—Thrombocytopenia—Cisplatin—bone cancer	0.00373	0.0102	CcSEcCtD
Triamterene—Hypokalaemia—Epirubicin—bone cancer	0.00363	0.00995	CcSEcCtD
Triamterene—Photosensitivity reaction—Methotrexate—bone cancer	0.00336	0.00922	CcSEcCtD
Triamterene—Hypokalaemia—Doxorubicin—bone cancer	0.00335	0.00921	CcSEcCtD
Triamterene—Photosensitivity reaction—Epirubicin—bone cancer	0.00314	0.00863	CcSEcCtD
Triamterene—Jaundice—Epirubicin—bone cancer	0.00299	0.00821	CcSEcCtD
Triamterene—Photosensitivity reaction—Doxorubicin—bone cancer	0.00291	0.00798	CcSEcCtD
Triamterene—Hypersensitivity—Cisplatin—bone cancer	0.00281	0.00771	CcSEcCtD
Triamterene—Jaundice—Doxorubicin—bone cancer	0.00277	0.0076	CcSEcCtD
Triamterene—Asthenia—Cisplatin—bone cancer	0.00274	0.00751	CcSEcCtD
Triamterene—Diarrhoea—Cisplatin—bone cancer	0.00261	0.00716	CcSEcCtD
Triamterene—Vomiting—Cisplatin—bone cancer	0.00242	0.00665	CcSEcCtD
Triamterene—Rash—Cisplatin—bone cancer	0.0024	0.0066	CcSEcCtD
Triamterene—Dermatitis—Cisplatin—bone cancer	0.0024	0.00659	CcSEcCtD
Triamterene—Nausea—Cisplatin—bone cancer	0.00226	0.00622	CcSEcCtD
Triamterene—Anaphylactic shock—Methotrexate—bone cancer	0.00209	0.00574	CcSEcCtD
Triamterene—Thrombocytopenia—Methotrexate—bone cancer	0.00205	0.00562	CcSEcCtD
Triamterene—Dry mouth—Epirubicin—bone cancer	0.002	0.00548	CcSEcCtD
Triamterene—Anaphylactic shock—Epirubicin—bone cancer	0.00196	0.00537	CcSEcCtD
Triamterene—Thrombocytopenia—Epirubicin—bone cancer	0.00192	0.00526	CcSEcCtD
Triamterene—Dry mouth—Doxorubicin—bone cancer	0.00185	0.00507	CcSEcCtD
Triamterene—Anaphylactic shock—Doxorubicin—bone cancer	0.00181	0.00497	CcSEcCtD
Triamterene—Fatigue—Methotrexate—bone cancer	0.0018	0.00495	CcSEcCtD
Triamterene—Thrombocytopenia—Doxorubicin—bone cancer	0.00177	0.00487	CcSEcCtD
Triamterene—Fatigue—Epirubicin—bone cancer	0.00169	0.00463	CcSEcCtD
Triamterene—Fatigue—Doxorubicin—bone cancer	0.00156	0.00429	CcSEcCtD
Triamterene—Hypersensitivity—Methotrexate—bone cancer	0.00154	0.00423	CcSEcCtD
Triamterene—Asthenia—Methotrexate—bone cancer	0.0015	0.00412	CcSEcCtD
Triamterene—Hypersensitivity—Epirubicin—bone cancer	0.00144	0.00396	CcSEcCtD
Triamterene—Diarrhoea—Methotrexate—bone cancer	0.00143	0.00393	CcSEcCtD
Triamterene—Asthenia—Epirubicin—bone cancer	0.0014	0.00386	CcSEcCtD
Triamterene—Dizziness—Methotrexate—bone cancer	0.00138	0.0038	CcSEcCtD
Triamterene—Diarrhoea—Epirubicin—bone cancer	0.00134	0.00368	CcSEcCtD
Triamterene—Hypersensitivity—Doxorubicin—bone cancer	0.00133	0.00366	CcSEcCtD
Triamterene—Vomiting—Methotrexate—bone cancer	0.00133	0.00365	CcSEcCtD
Triamterene—Rash—Methotrexate—bone cancer	0.00132	0.00362	CcSEcCtD
Triamterene—Dermatitis—Methotrexate—bone cancer	0.00132	0.00362	CcSEcCtD
Triamterene—Headache—Methotrexate—bone cancer	0.00131	0.0036	CcSEcCtD
Triamterene—Asthenia—Doxorubicin—bone cancer	0.0013	0.00357	CcSEcCtD
Triamterene—Dizziness—Epirubicin—bone cancer	0.00129	0.00355	CcSEcCtD
Triamterene—Vomiting—Epirubicin—bone cancer	0.00124	0.00342	CcSEcCtD
Triamterene—Nausea—Methotrexate—bone cancer	0.00124	0.00341	CcSEcCtD
Triamterene—Diarrhoea—Doxorubicin—bone cancer	0.00124	0.0034	CcSEcCtD
Triamterene—Rash—Epirubicin—bone cancer	0.00123	0.00339	CcSEcCtD
Triamterene—Dermatitis—Epirubicin—bone cancer	0.00123	0.00339	CcSEcCtD
Triamterene—Headache—Epirubicin—bone cancer	0.00123	0.00337	CcSEcCtD
Triamterene—Dizziness—Doxorubicin—bone cancer	0.0012	0.00329	CcSEcCtD
Triamterene—Nausea—Epirubicin—bone cancer	0.00116	0.00319	CcSEcCtD
Triamterene—Vomiting—Doxorubicin—bone cancer	0.00115	0.00316	CcSEcCtD
Triamterene—Rash—Doxorubicin—bone cancer	0.00114	0.00314	CcSEcCtD
Triamterene—Dermatitis—Doxorubicin—bone cancer	0.00114	0.00313	CcSEcCtD
Triamterene—Headache—Doxorubicin—bone cancer	0.00113	0.00312	CcSEcCtD
Triamterene—Nausea—Doxorubicin—bone cancer	0.00108	0.00295	CcSEcCtD
